| Gennex Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531739 |
NSE Symbol : - |
P/E(TTM) : 22.53 |
|
ISIN Demat : INE509C01026 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.60 |
|
Book Value(₹) : 8.67 |
Market Cap(₹Cr) : 328.47 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 29.33 | 25.64 | 23.28 | 25.28 | 24.69 | 21.33 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 29.33 | 25.64 | 23.28 | 25.28 | 24.69 | 21.33 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 2.07 | 1.82 | 0.00 |
| Other Income | 2.04 | 2.26 | 2.87 | 0.00 | 0.00 | 2.46 |
| Total Income | 31.37 | 27.90 | 26.15 | 27.35 | 26.51 | 23.79 |
| Total Expenditure | 25.37 | 22.26 | 23.21 | 21.78 | 20.98 | 18.41 |
| PBIDT | 5.99 | 5.64 | 2.94 | 5.56 | 5.53 | 5.38 |
| Interest | 0.55 | 0.59 | 0.53 | 0.41 | 0.47 | 0.29 |
| PBDT | 5.44 | 5.05 | 2.40 | 5.16 | 5.06 | 5.09 |
| Depreciation | 0.21 | 0.20 | 0.23 | 0.20 | 0.05 | 0.17 |
| Tax | 0.70 | 0.70 | 0.62 | 0.75 | 0.85 | 0.75 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 4.53 | 4.15 | 1.50 | 4.21 | 4.16 | 4.17 |
| Extra-ordinary Items | 0.00 | 0.00 | -0.10 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 4.53 | 4.15 | 1.60 | 4.21 | 4.16 | 4.17 |
| EPS (Unit Curr.) | 0.19 | 0.18 | 0.07 | 0.19 | 0.18 | 0.18 |
| EPS (Adj) (Unit Curr.) | 0.19 | 0.18 | 0.07 | 0.19 | 0.18 | 0.18 |
| Calculated EPS (Unit Curr.) | 0.19 | 0.18 | 0.07 | 0.19 | 0.18 | 0.18 |
| Calculated EPS (Adj) (Unit Curr.) | 0.19 | 0.18 | 0.07 | 0.19 | 0.18 | 0.18 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.75 | 0.72 | 0.26 | 0.74 | 0.73 | 0.73 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.75 | 0.72 | 0.26 | 0.74 | 0.73 | 0.73 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 24.29 | 23.14 | 22.74 | 22.74 | 22.74 | 22.74 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 20.42 | 22.00 | 12.63 | 21.99 | 22.40 | 25.22 |
| PBDTM(%) | 18.55 | 19.70 | 10.31 | 20.41 | 20.49 | 23.86 |
| PATM(%) | 15.44 | 16.19 | 6.44 | 16.65 | 16.85 | 19.55 |